My NCBISign In
Cost-effectiveness of micafungin as an alternative to fluconazole empiric treatment of suspected ICU-acquired candidemia among patients with sepsis: a model simulation
Marya D Zilberberg, Smita Kothari, Andrew F Shorr
Crit Care. 2009; 13(3): R94. Published online 2009 June 19. doi: 10.1186/cc7924
PMCID:
PMC2717466
Abstract Full Text PDF–390K Supplementary Material

Is Cited by the Following 3 Articles in this Archive:

Pharmacology and metabolism of anidulafungin, caspofungin and micafungin in the treatment of invasive candidosis - review of the literature
G Kofla, M Ruhnke
Eur J Med Res. 2011; 16(4): 159–166. Published online 2011 April 28. doi: 10.1186/2047-783X-16-4-159
PMCID:
PMC3352072
Abstract Full Text PDF–1.0M
Year in review 2009: Critical Care - infection
Stephan Harbarth, Thomas Haustein
Crit Care. 2010; 14(6): 240. Published online 2010 November 5. doi: 10.1186/cc9268
PMCID:
PMC3220050
Abstract Full Text PDF–164K
Empiric anti-Candida therapy for patients with sepsis in the ICU: how little is too little?
Yoav Golan
Crit Care. 2009; 13(4): 180. Published online 2009 August 21. doi: 10.1186/cc7977
PMCID:
PMC2750174
Abstract Full Text PDF–47K
You are here: NCBI > Literature > PubMed Central (PMC)
Write to the Help Desk